115 related articles for article (PubMed ID: 21183370)
41. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA).
Stefan H; Wang-Tilz Y; Pauli E; Dennhöfer S; Genow A; Kerling F; Lorber B; Fraunberger B; Halboni P; Koebnick C; Gefeller O; Tilz C
Epilepsia; 2006 Mar; 47(3):516-22. PubMed ID: 16529615
[TBL] [Abstract][Full Text] [Related]
42. Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial.
Nurmikko TJ; Serpell MG; Hoggart B; Toomey PJ; Morlion BJ; Haines D
Pain; 2007 Dec; 133(1-3):210-20. PubMed ID: 17997224
[TBL] [Abstract][Full Text] [Related]
43. Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study.
Rossi S; Mataluni G; Codecà C; Fiore S; Buttari F; Musella A; Castelli M; Bernardi G; Centonze D
Eur J Neurol; 2009 Mar; 16(3):360-6. PubMed ID: 19364364
[TBL] [Abstract][Full Text] [Related]
44. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
[TBL] [Abstract][Full Text] [Related]
45. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
46. The NK1-receptor antagonist TKA731 in painful diabetic neuropathy: a randomised, controlled trial.
Sindrup SH; Graf A; Sfikas N
Eur J Pain; 2006 Aug; 10(6):567-71. PubMed ID: 16199188
[TBL] [Abstract][Full Text] [Related]
47. The effect of levetiracetam on focal nocturnal epileptiform activity during sleep--a placebo-controlled double-blind cross-over study.
Larsson PG; Bakke KA; Bjørnæs H; Heminghyt E; Rytter E; Brager-Larsen L; Eriksson AS
Epilepsy Behav; 2012 May; 24(1):44-8. PubMed ID: 22494796
[TBL] [Abstract][Full Text] [Related]
48. Effect of minocycline on lumbar radicular neuropathic pain: a randomized, placebo-controlled, double-blind clinical trial with amitriptyline as a comparator.
Vanelderen P; Van Zundert J; Kozicz T; Puylaert M; De Vooght P; Mestrum R; Heylen R; Roubos E; Vissers K
Anesthesiology; 2015 Feb; 122(2):399-406. PubMed ID: 25373391
[TBL] [Abstract][Full Text] [Related]
49. Escitalopram in painful polyneuropathy: a randomized, placebo-controlled, cross-over trial.
Otto M; Bach FW; Jensen TS; Brøsen K; Sindrup SH
Pain; 2008 Oct; 139(2):275-283. PubMed ID: 18547727
[TBL] [Abstract][Full Text] [Related]
50. The anticonvulsant levetiracetam potentiates alcohol consumption in non-treatment seeking alcohol abusers.
Mitchell JM; Grossman LE; Coker AR; Messing RO
J Clin Psychopharmacol; 2012 Apr; 32(2):269-72. PubMed ID: 22367657
[TBL] [Abstract][Full Text] [Related]
51. Valproic acid has no effect on pain in polyneuropathy: a randomized, controlled trial.
Otto M; Bach FW; Jensen TS; Sindrup SH
Neurology; 2004 Jan; 62(2):285-8. PubMed ID: 14745070
[TBL] [Abstract][Full Text] [Related]
52. Levetiracetam in the treatment of alcohol dependence: toward the end of the story?
Le Strat Y
Alcohol Clin Exp Res; 2012 Aug; 36(8):1309-10. PubMed ID: 22823576
[TBL] [Abstract][Full Text] [Related]
53. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial.
Sindrup SH; Bach FW; Madsen C; Gram LF; Jensen TS
Neurology; 2003 Apr; 60(8):1284-9. PubMed ID: 12707430
[TBL] [Abstract][Full Text] [Related]
54. Enriched enrollment randomized double-blind placebo-controlled cross-over trial with phenytoin cream in painful chronic idiopathic axonal polyneuropathy (EPHENE): a study protocol.
Kopsky DJ; van Eijk RPA; Warendorf JK; Keppel Hesselink JM; Notermans NC; Vrancken AFJE
Trials; 2022 Oct; 23(1):888. PubMed ID: 36273216
[TBL] [Abstract][Full Text] [Related]
55. A prehospital randomized trial in convulsive status epilepticus.
Navarro V; Dagron C; Demeret S; An K; Lamhaut L; Bolgert F; Baulac M; Carli P
Epilepsia; 2011 Oct; 52 Suppl 8():48-9. PubMed ID: 21967362
[TBL] [Abstract][Full Text] [Related]
56. [The effectiveness of levetiracetam in the treatment of neuropathic pain].
Del Pozo E; Pereira-Pérez E; González-Contreras LG
Rev Neurol; 2011 Jul; 53(2):65-72. PubMed ID: 21720975
[TBL] [Abstract][Full Text] [Related]
57. Impact of etiology and duration of pain on pharmacological treatment effects in painful polyneuropathy.
Sindrup SH; Holbech J; Demant D; Finnerup NB; Bach FW; Jensen TS
Eur J Pain; 2017 Sep; 21(8):1443-1450. PubMed ID: 28557178
[TBL] [Abstract][Full Text] [Related]
58. The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study.
Demant DT; Lund K; Vollert J; Maier C; Segerdahl M; Finnerup NB; Jensen TS; Sindrup SH
Pain; 2014 Nov; 155(11):2263-73. PubMed ID: 25139589
[TBL] [Abstract][Full Text] [Related]
59. A randomized, controlled trial of a β2-agonist in painful polyneuropathy.
Gillving M; Demant D; Holbech JV; Gylfadottir SS; Bach FW; Jensen TS; Finnerup NB; Sindrup SH
Pain; 2021 May; 162(5):1364-1373. PubMed ID: 33181580
[TBL] [Abstract][Full Text] [Related]
60. A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients.
Fertig JB; Ryan ML; Falk DE; Litten RZ; Mattson ME; Ransom J; Rickman WJ; Scott C; Ciraulo D; Green AI; Tiouririne NA; Johnson B; Pettinati H; Strain EC; Devine E; Brunette MF; Kampman K; A Tompkins D; Stout R;
Alcohol Clin Exp Res; 2012 Aug; 36(8):1421-30. PubMed ID: 22324516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
